Guest guest Posted May 7, 2010 Report Share Posted May 7, 2010 From: U.S. Food & Drug Administration (FDA) <fda@...>Subject: CDER New May 6, 2010sees_things@...Date: Friday, May 7, 2010, 11:17 AM CDER New May 6, 2010 New and Generic Drug Approvals May 6, 2010 Aptivus (tipranavir) Capsules, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision Invarase (saquinavir mesylate) Capsules, Hoffmann-La Roche Inc., Labeling Revision Kaletra (lopinavir and ritonavir) Tablets, Abbott Laboratories, Patient Population Altered Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Patient Population Altered Norvir (ritonavir) Capsules, Abbott Laboratories, Labeling Revision Tamsulosin Hydrochloride Capsules, Synthon Pharmaceuticals, Inc., Approval Tamsulosin Hydrochloride Capsules, Sandoz Inc., Approval Tamsulosin Hydrochloride Capsules, Zydus Pharmaceuticals Inc., Approval Tamsulosin Hydrochloride Capsules, Wockhardt, Approval Tamsulosin Hydrochloride Capsules, TEVA Pharmaceuticals, Approval Tamsulosin Hydrochloride Capsules, Mylan Pharmaceuticals, Inc., Approval Votrient (pazopanib hydrochloride) Tablets, GlaxoKline, Labeling Revision Zyprexa Relprevv (olanzapine pamoate) Extended-Release Intramuscular Suspension, Eli Lilly and Company, Labeling Revision Manage your FDA Subscriptions: Update your preferences or unsubscribe Questions about this service? support@... Other inquiries? webmail@... GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.